NASDAQ · LGND
Ligand Pharmaceuticals Incorporated
$317.33-$1.45 (-0.45%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
Loading market information…
OTC · SOFE · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
SOAFEE, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow SOAFEE, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SOAFEE, Inc. provides artificial intelligence (AI) and information technology (IT) services, and enterprise AI software-as a-service (SaaS) solutions for enterprises. It offers AI driven data as a service system (DaaS); SOAFEE healthcare marketplace; applied AI IT services for the health care/life sciences sector; and applied AI SaaS solutions for optimizing business operations. The company was formerly known as Carepay, Inc. and changed its name to SOAFEE, Inc. in February 2022. SOAFEE, Inc. is based in Atlanta, Georgia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$317.33-$1.45 (-0.45%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
$0.00$0.00 (0.0%)
Nutranomics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Medixall Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 41.07% below the high.
$0.00$0.00 (0.0%)
Health Discovery Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Medical Imaging Corp.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
$0.00$0.00 (0.0%)
Interactive Health Network’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Wellness Matrix Group, Inc.: Healthcare · Medical - Healthcare Information Services.
$0.00$0.00 (0.0%)
Veritas Farms, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.83% below the high.
